Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware. more
Dec '20 | Dec '21 | Dec '22 | Dec '23 | |||
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Cost of Revenue | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Gross Profit | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Gross Margin | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Operating Expenses | 11.77M | 35.67M | 45.13M | 40.27M | [{"date":"2020-12-31","value":26.07,"profit":true},{"date":"2021-12-31","value":79.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.23,"profit":true}] | |
Operating Income | (11.77M) | (35.67M) | (45.13M) | (40.27M) | [{"date":"2020-12-31","value":-1176700000,"profit":false},{"date":"2021-12-31","value":-3567200000,"profit":false},{"date":"2022-12-31","value":-4513500000,"profit":false},{"date":"2023-12-31","value":-4027500000,"profit":false}] | |
Total Non-Operating Income/Expense | - | - | (109.00K) | 5.16M | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-2.11,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] | |
Pre-Tax Income | (20.67M) | (47.48M) | (45.24M) | (35.12M) | [{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}] | |
Income Taxes | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Income After Taxes | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Income From Continuous Operations | (20.67M) | (47.48M) | (45.24M) | (35.12M) | [{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}] | |
Income From Discontinued Operations | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Net Income | (20.67M) | (47.48M) | (45.24M) | (35.12M) | [{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}] | |
EPS (Diluted) | - | (1.23) | (1.71) | (1.31) | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-122.85,"profit":false},{"date":"2022-12-31","value":-171.4,"profit":false},{"date":"2023-12-31","value":-131.39,"profit":false}] | |
These ratios help you determine the liquidity of the company. Higher is better.
CLYM | |
---|---|
Current Ratio | 60.41 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CLYM | |
---|---|
ROA (LTM) | 0.00% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CLYM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.02 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.98 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CLYM | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.00 |
EV/R | 0.00 |
EV/Ebitda | NM |
Climb Bio Inc (CLYM) share price today is $2.6
Yes, Indians can buy shares of Climb Bio Inc (CLYM) on Vested. To buy Climb Bio Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLYM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Climb Bio Inc (CLYM) via the Vested app. You can start investing in Climb Bio Inc (CLYM) with a minimum investment of $1.
You can invest in shares of Climb Bio Inc (CLYM) via Vested in three simple steps:
The 52-week high price of Climb Bio Inc (CLYM) is $11.55. The 52-week low price of Climb Bio Inc (CLYM) is $2.52.
The price-to-earnings (P/E) ratio of Climb Bio Inc (CLYM) is
The price-to-book (P/B) ratio of Climb Bio Inc (CLYM) is 0.00
The dividend yield of Climb Bio Inc (CLYM) is 0.00%
The market capitalization of Climb Bio Inc (CLYM) is
The stock symbol (or ticker) of Climb Bio Inc is CLYM